IL3 and neoplasm: The release of protein material through necrotic changes as well as cytokines such as interleukin‐5 (interleukin [IL]‐5), IL‐3 and eotaxin‐1 produced by tumour or host inflammatory cells attract eosinophils to neoplastic tissue.